Clinical Trials Logo
  1. Home
  2. TB
  3. NCT01055145

Comparison of the Effect Between Levofloxacin and Moxifloxacin Among MDR-TB Patients

TB Clinical Trial

Official title:
Comparison of the Effect Between Levofloxacin and Moxifloxacin on the Culture Conversion After 3 Months Treatment Among MDR-TB Patients; Prospective Multicenter Randomized Open Label Phase III Trial

Clinical Trial Summary

Fluoroquinolone is a one of the most important drugs for treatment of multidrug-resistant TB (MDR-TB). Among them, levofloxacin and moxifloxacin has been used most widely. However, there is no study to directly compare the efficacy of levofloxacin and moxifloxacin among MDR-TB patients. The investigators will compare the efficacy of levofloxacin and moxifloxacin through a prospective multicenter randomized open label phase III trial.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01055145
Study type Interventional
Source Seoul National University Hospital
Contact
Status Terminated
Phase Phase 3
Start date March 2010
Completion date October 2012
View Details
See also
  Status Clinical Trial Phase
Completed NCT04645836 - Impact of a Pharmacist-led Patient-centred Care Intervention Along With Text-Message Reminders, on the Management of Newly Diagnosed Tubercular Patients: a Protocol for a Randomized Controlled Trial'. N/A
Completed NCT00480454 - Safety, Immunogenicity, and Impact of MVA85A, on the Immunogenicity of the EPI Vaccines Phase 1
Active, not recruiting NCT03208725 - Childhood Acute Illness and Nutrition Network
Completed NCT00480688 - A Study of the Immunogenicity of M. Bovis BCG, Delivered Intradermally in Healthy Volunteers Phase 1
Completed NCT00480714 - A Study of the Immunogenicity of BCG, Delivered Intradermally in Healthy Volunteers N/A
Active, not recruiting NCT04298905 - Leveraging mHealth to Enable and Adapt CHW Strategies to Improve TB/HIV Patient Outcomes in SA N/A
Completed NCT00480558 - A Study of MVA85A, in Asymptomatic Volunteers Infected With TB, HIV or Both Phase 1
Withdrawn NCT00424684 - Comparison of the Quantiferon®-TB GOLD (in Tube) Assay With Tuberculin Skin Testing for Detecting Latent Tuberculosis Infection in Patients With Chronic Liver Disease Being Evaluated for or Awaiting Liver Transplantation N/A
Recruiting NCT04673227 - Cytometric Immunodiagnostics of Latent Tuberculosis Infection (LTBI)
Completed NCT00654316 - Study of the Safety and Immunogenicity of Bacille Calmette Guerin (BCG) Vaccine Phase 1
Active, not recruiting NCT05405296 - Evaluation of the Truenat™MTB Plus/COVID-19 Test for TB (Tuberculosis) and COVID-19 (SARS-CoV2)